Jason K. Gross is a Member of the Firm’s Corporate Department. He also serves as Co-Chair of the International | U.S. Cross Border Practice Group and the Cannabis Industry Practice Group. As counsel to public and private companies, both national and international, Mr. Gross is actively involved in transactional matters involving acquisitions, dispositions and corporate governance. Mr. Gross acts as outside counsel for several U.S. subsidiaries of a multi-billion dollar, foreign manufacturing conglomerate. In this capacity, he is involved in commercial transactions, operational and employment-related agreements, and resolving business disputes.

Mr. Gross has a growing practice representing companies in the pharmaceutical/medical device and gaming/hospitality and European apparel industries in connection with matters ranging from M&A transactions, compliance programs, regulatory hearings, off-label marketing, cross-licensing agreements, distribution agreements and strategic alliances. In his practice, Mr. Gross has acted as financial counsel to health care providers in transactions involving tax-exempt and taxable bond and note financings and secured lines of credit. Mr. Gross has counseled cannabis clients in Arizona, Nevada, New Jersey and Texas on cannabis industry matters ranging from acquisitions and capital raising to corporate structuring and licensing.

Mr. Gross previously served as Corporate Counsel to Caesars Entertainment Inc., a Fortune 500 gaming, lodging and entertainment company. His work as Corporate Counsel has enabled him to apply practical business knowledge to any legal strategy. In connection therewith, Mr. Gross was licensed by the New Jersey Casino Control Commission as a Key Employee. Mr. Gross has also represented clients before various gaming and cannabis regulatory agencies.


  • Corporate
  • International | U.S. Cross-Border
  • Cannabis
  • Mergers and Acquisitions
  • Corporate Governance

Expand All

Representative Matters

    • Representation of an international company in the $300 million acquisition of a diagnostic products business of a large, international company.
    • Representation of an international company in the $58 million acquisition of a diagnostic products division of a large, international company.
    • Representation of a medical marijuana business in Arizona in connection with sale to publicly traded Canadian corporation in excess of $25 million.
    • Representation of a New-Jersey CBD company in sale to publicly traded Canadian corporation for consideration in excess of $15 million.
    • Representation of several businesses applying for a permit to operate a Medical Marijuana Alternative Treatment Center in New Jersey, including 1 (one) of the 6 (six) applicants selected by the New Jersey Division of Health to open a new ATC.
    • Representation of a leading hospital system in the issuance of approximately $750 million revenue bonds (tax-exempt) by the New Jersey Health Care Facilities Financing Authority.
    • Representation of a leading hospital system in the implementation and negotiation of gateway services and eCheck settlement solutions for credit card transaction processing.
    • Representation of a well-known U.S. food chain franchisor in negotiations with existing franchisees regarding terms and conditions of their franchise agreements and provide advice and counsel to franchisor regarding advertising and other rights and obligations of the parties.
    • Representation of a plant-based alternative seafood company in a $8.7 million Series A financing and corporate initiatives and strategy.
    • Representation of an energy beverage company in connection with investments by strategic investors.
    • Representation of a baked good company in connection with negotiating an enterprise resource planning (ERP) solution.
    • Representation of an international company in the acquisition of a manufacturing facility from an automotive company.
    • Representation of a publicly-listed retail chain in its sale to a private investment firm.
    • Representation of a publicly-listed high-tech company in a proposed merger of equals which involved a hostile proxy contest.
    • Representation of an international company that produces and sells melted iron, aluminum and magnesium components for the automotive industry in the purchase of a 25-percent interest in an iron foundry.
    • Representation of a U.S. affiliate of a foreign company in the negotiation and drafting of distribution agreements for the sale of gasoline, natural gas and marine diesel engines, and industrial generating sets throughout the U.S., Mexico and Canada.
    • Representation of a parking enforcement solutions provider in the national roll-out of its products and services.
    • Representation of a person-to-person Internet consumer lending site in connection with its creation and establishment of the company.
    • Representation of a leadership training company in connection with its development, including advice, counseling and preparation of agreements.
    • Representation of a medical device company in acquisitions, distribution, sales, marketing and R&D matters.




Rankings and Recognition

  • Selected for inclusion in:
  • The Best Lawyers in America®* 2020-2023, Corporate Law
  • New Jersey Super Lawyers®* "Rising Stars" 2006-2007

* See Award Methodology. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.


  • J.D., Benjamin N. Cardozo School of Law at Yeshiva University

    Editor-in-Chief, New Europe Law Review

  • B.A., Emory University

Bar Admissions

  • New Jersey
  • New York